Other less potent drivers of GLP1: In the current study, we conclude that certain herbal-based constituents, such as berberine, tea, curcumin, cinnamon, wheat, soybean, resveratrol, and gardenia, can exert an influence on GLP-1 release
[18] MedlinePlus
This doesnt mean the medication failedit reflects that for most people, obesity is a chronic condition requiring ongoing management, similar to blood pressure or cholesterol medications
Visceral adipose tissue releases free fatty acids directly into the portal circulation, increasing hepatic very-low-density lipoprotein (VLDL) production
Starting pelvic floor exercises early when beginning GLP-1 medications may help keep your pelvic floor muscles strong and healthy as your body adjusts to weight loss and possible muscle mass changes
Retatrutide appears in clinical-trial literature for obesity and metabolic disease (Phase III as of 2025-2026)